DALE MEDICAL CENTER — History
CCN 010021 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$34M
Latest Revenue (FY2022)
-1.0%
Revenue CAGR (3yr)
-18.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $34M | $39M | $34M | -12.9% | -1.0% |
| Operating Expenses | $43M | $40M | $40M | -0.8% | -3.4% |
| Operating Margin | -24.4% | -3.9% | -18.4% | -371.4% | +0.0% |
| Net Income | $-8M | $-2M | $-6M | -310.5% | +0.0% |
| Licensed Beds | 77 | 77 | 77 | +0.0% | +0.0% |
| Total Patient Days | 8,768 | 8,362 | 6,851 | -18.1% | -11.6% |
| Medicare Day % | 25% | 24% | 23% | -3.4% | -3.8% |
| Medicaid Day % | 16% | 17% | 18% | +7.8% | +6.8% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: -1.9% ($34M → $34M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.0%
This Hospital
+7.6%
State Avg
Latest Margin
-18.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $33M | -15.4% |
| FY2024 (proj) | $33M | -12.5% |
| FY2025 (proj) | $33M | -9.5% |